Ae Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ae Wealth Management LLC

$9.76 Billion
Q3 2024

A detailed history of Ae Wealth Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ae Wealth Management LLC holds 1,074 shares of REGN stock, worth $812,813. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,074

Previous 547 96.34%

Holding current value

$812,813

Previous $574,000 96.69%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $539,695 - $633,327	527 Added 96.34%	1,074 $1.13 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $78,604 - $95,335	89 Added 19.43%	547 $574,000
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $2.9 Million - $3.19 Million	-3,210 Reduced 87.51%	458 $440,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $1.9 Million - $2.16 Million	2,450 Added 201.15%	3,668 $3.22 Million
Q3 2023 Oct 11, 2023	SELL	$692.45 - $844.37 $1.41 Million - $1.71 Million	-2,031 Reduced 62.51%	1,218 $1 Million
Q2 2023 Jul 10, 2023	SELL	$700.03 - $830.35 $441,718 - $523,950	-631 Reduced 16.26%	3,249 $2.33 Million
Q1 2023 Apr 14, 2023	SELL	$680.49 - $826.97 $460,691 - $559,858	-677 Reduced 14.86%	3,880 $3.19 Million
Q4 2022 Jan 31, 2023	SELL	$705.89 - $766.39 $5.92 Million - $6.43 Million	-8,384 Reduced 64.79%	4,557 $3.29 Million
Q3 2022 Oct 25, 2022	BUY	$573.97 - $724.32 $47,065 - $59,394	82 Added 0.64%	12,941 $8.91 Million
Q2 2022 Aug 03, 2022	BUY	$548.35 - $738.84 $1.56 Million - $2.1 Million	2,845 Added 28.41%	12,859 $7.6 Million
Q1 2022 Apr 18, 2022	BUY	$595.12 - $698.43 $104,741 - $122,923	176 Added 1.79%	10,014 $6.99 Million
Q4 2021 Jan 20, 2022	BUY	$543.48 - $670.97 $3.08 Million - $3.8 Million	5,658 Added 135.36%	9,838 $6.21 Million
Q3 2021 Nov 01, 2021	SELL	$574.03 - $680.96 $97,011 - $115,082	-169 Reduced 3.89%	4,180 $2.53 Million
Q2 2021 Jul 21, 2021	BUY	$472.8 - $558.54 $284,152 - $335,682	601 Added 16.04%	4,349 $2.43 Million
Q1 2021 Apr 27, 2021	BUY	$446.73 - $548.2 $1.36 Million - $1.67 Million	3,044 Added 432.39%	3,748 $1.77 Million
Q4 2020 Feb 01, 2021	SELL	$478.3 - $607.98 $686,838 - $873,059	-1,436 Reduced 67.1%	704 $340,000
Q3 2020 Nov 06, 2020	BUY	$544.75 - $658.21 $128,561 - $155,337	236 Added 12.39%	2,140 $1.2 Million
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $253,566 - $330,974	514 Added 36.98%	1,904 $1.19 Million
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $271,633 - $399,499	808 Added 138.83%	1,390 $679,000
Q4 2019 Jan 15, 2020	BUY	$274.13 - $376.51 $159,543 - $219,128	582 New	582 $219,000
Q3 2019 Nov 05, 2019	SELL	$273.46 - $318.39 $192,789 - $224,464	-705 Closed	0 $0
Q2 2019 Jul 22, 2019	BUY	$299.6 - $414.82 $211,218 - $292,448	705 New	705 $221,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $173,069 - $215,791	-548 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$358.63 - $469.95 $196,529 - $257,532	548	548 $206,000

Others Institutions Holding REGN

# of Institutions

1,524

Shares Held

84M

Call Options Held

1.14M

Put Options Held

1.48M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Account

Ae Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History